about
[Diagnosis related groups in stroke treatment. An analysis from the stroke data bank of the German Stroke Foundation].[Nationwide statements from regional data: methods of the Center for Cancer Registry Data].[Epidemiological cancer data online: an overview of information service in Germany and Europe].Stroke risk perception among participants of a stroke awareness campaign.[Linkage of data of the medical service of the health insurances with data of a cancer registry].New malignancies following cancer of the urinary bladder: analysis of German cancer registry data.Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models.Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999-2011. A population-based cancer registry analysisIncidence of lip malignancies in Germany-data from nine population-based cancer registries.Development and implementation of evidence-based indicators for measuring quality of acute stroke care: the Quality Indicator Board of the German Stroke Registers Study Group (ADSR).Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century.Incidence of malignant mesothelioma in Germany 2009-2013.Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study.Incident cancers attributable to alcohol consumption in Germany, 2010.Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011.Cancer incidence in Germany attributable to human papillomavirus in 2013.[The future incidence of colorectal and lung cancers: results of the calculation of different scenarios for the year 2020].Epidemiology in a globalising world: new challenges for researchers.Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site.Symptomatic intracranial atherosclerotic stenoses: prevalence and prognosis in patients with acute cerebral ischemia.Assessment of functioning and disability after ischemic stroke.[Esophageal Adenocarcinoma - Appraisal of a Rapidly Increasing Disease].Changes in cancer incidence attributable to tobacco smoking in Germany, 1999-2008.Stroke mortality and morbidity attributable to passive smoking in Germany.[Clinical presentation and prognosis of brain stem infarcts. An evaluation of the Stroke Databank of the German Stroke Foundation]Intravenous thrombolysis in German stroke units before and after regulatory approval of recombinant tissue plasminogen activatorMortality and morbidity from coronary heart disease attributable to passive smoking[Epidemiology of prostate cancer: recent results from the Epidemiological Cancer Register of the District of Münster (Germany)][Patent foramen ovale, atrial septum aneurysm, and stroke. An examination of the status of recent evidence]Recurrent stroke after cervical artery dissection[Epidemiological cancer registration in Germany: an impressive research resource][Leukemia incidence and survival in Germany according to current standardized categories][Prognosis of population-related morbidity for common cancers in Germany--Effects on health care]
P50
Q30711944-7D2B3EDC-CA47-408B-AFE2-918FA39D3D8CQ30719759-8CD49011-6A7A-4240-8E35-42DEB711687EQ30719765-5DEF4AC1-F9FA-43CD-9B0F-EB9D1B49D096Q33279364-083B8E5D-B3B5-44F3-8946-FE0DF836CB94Q34052039-2C9072E0-4C7A-4D05-94E6-EA51931C6A96Q34094610-B1F7142A-DCC1-41F2-B505-7699B98CD893Q34284921-B64D469C-952C-4B5F-94B8-1CFC5C4E89E9Q35644706-6192F34A-51A7-4B28-8B06-A24D8987B6E7Q36274410-8C275DBB-C3F0-4E38-9BD2-32B3D457C009Q36588818-6D22A623-B5AB-4477-BD34-EE2780B50F9DQ37360066-2C585437-6275-48BD-851D-4894E99C51EFQ39062992-C01AA66D-2E10-4C11-A8D3-9B678B3FD563Q39400229-11DBD827-C5FD-41B7-9FCC-934FDB8CA9B8Q41173338-24D35A60-1EAA-410C-997B-DC5015AE4164Q41224004-BB264657-0D54-4C0B-B32C-B8CF294123CAQ42690795-874A41AB-43AF-4321-9052-B68718A2EFB1Q43871053-7601AF8F-00C3-42E3-B99A-73CFF62287BAQ44547900-2B497D0E-36CC-4CB2-B743-A09B17684389Q47228945-146FDF11-0B33-4D50-AC4B-18317A7D71F3Q48147738-17920506-31F5-46DC-90A7-6BB94B61C0E1Q48523548-428785F7-B831-473D-AEB5-3D18817C1D7DQ49921155-3AD2F833-677A-4106-AED8-7109CBBF8D84Q50790738-79C32A71-9E23-47A2-9BA0-8BF02D583320Q64953098-030A787D-4607-412B-8C37-CD94BA1C828BQ78006396-72D2BDF7-4ED6-4C17-99BD-C903240C2F2DQ80123349-4A4D5140-8DB8-4598-B527-9AD28FBADDC7Q80346200-A7968973-81E3-403E-90C2-FB7EA7E4AB23Q81044771-3DE2CCA8-9D53-494D-BED9-4EA409EF3DC5Q81371166-5883770B-93F7-463C-8A69-20108FD31C6BQ84651300-59E97F6B-01FC-4EDA-9B23-80EAFB026C0EQ86983917-8190DD7B-8F15-4E35-B6EF-5948964E3B7EQ86983946-2FBED0D7-1161-436D-B6B8-E24B2D9F2CB1Q87212029-8844F281-84CC-4209-9144-9D78B70419CE
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Klaus Kraywinkel
@ast
Klaus Kraywinkel
@en
Klaus Kraywinkel
@es
Klaus Kraywinkel
@nl
Klaus Kraywinkel
@sl
type
label
Klaus Kraywinkel
@ast
Klaus Kraywinkel
@en
Klaus Kraywinkel
@es
Klaus Kraywinkel
@nl
Klaus Kraywinkel
@sl
prefLabel
Klaus Kraywinkel
@ast
Klaus Kraywinkel
@en
Klaus Kraywinkel
@es
Klaus Kraywinkel
@nl
Klaus Kraywinkel
@sl
P106
P1153
6507121640
P31
P496
0000-0002-9250-6003